[KUALA LUMPUR] DXN Holdings Bhd's owners are exploring a sale of the Malaysian health supplement producer, in a deal that could value the firm at as much as US$1 billion including debt, people with knowledge of the matter said.
Shareholders of DXN, including South-east Asian private equity firm KV Asia Capital, are working with an adviser on the potential deal, according to the people. They are also considering an initial public offering of the business, the people said, asking not to be identified because the information is private.mushrooms, touted in traditional Chinese medicine as having near-miraculous properties including promoting longevity, boosting immunity and treating conditions from liver disease to cancer.It also distributes dietary supplements and food items like cordyceps coffee and spirulina cereal, as well as skin care products and cosmetics.